title: Tuberculosis preventive chemotherapy: the times they are a-changin'.
authors.affiliation: Heart of England Foundation Trust, Birmingham, UK; University of Warwick, Coventry, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: Dedicoat
authors.affiliation: Division of Clinical Infectious Diseases, Research Center Borstel, Germany; German Center for Infection Research, Clinical Tuberculosis Center, Borstel, Germany; International Health / Infectious Diseases, University of Lübeck, Lübeck, Germany; Department of Medicine, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Namibia School of Medicine, Windhoek, Namibia.
authors.forename: Christoph
authors.initials: C
authors.lastname: Lange
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage*; D055985:Latent Tuberculosis / Q000188:drug therapy*; D008297:Male; D012293:Rifampin / Q000031:analogs & derivatives*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin